参考文献/References:
[1] 李宁,王拥军,施杞,等.膝骨性关节炎的中医药防治研究进展[J].中国中医骨伤科杂志,2013,21(5):62-65.
[2] Xu WD,Zhao Y,Liu Y.Role of the TWEAK/Fn14 pathway in autoimmune diseases[J].Immunol Res,2016,64(1):44-50.
[3] Dionne S,Levy E,Levesque D,et al.PPAR gamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis[J].Anticancer Res,2010,30(1):157-166.
[4] Winkles JA.The TWEAK-Fn14 cytokine-receptor axis:discovery,biology and therapeutic targeting[J].Nat Rev Drug Discov,2008,7(5):411-425.
[5] 陈悦,赵明才.肿瘤坏死因子样凋亡微弱诱导剂在骨关节炎中的作用[J].中华临床医师杂志:电子版,2011,5(18):5392-5496.
[6] 中华医学会骨科分会.骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796.
[7] Zhang Z,Fang Y,Wang Q,et al.Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway[J].Mol Med Rep,2015,12(1):1499-1505.
[8] Cherry EM,Lee DW,Jung JU,et al.Tumor necrosis factor-like weak inducer of apoptosis(TWEAK)promotes glioma cell invasion through induction of NF-κB-inducing kinase(NIK)and noncanonical NF-κB signaling[J].Mol Cancer,2015,14:9.
[9] 蔡国平,俞永林,熊敏,等.TWEAK及其受体Fn14在大鼠骨关节炎(OA)关节软骨和滑膜中的表达[J].复旦学报:医学版,2013,40(3):265-270.
[10] 陈琼,赵明才,蒋萍,等.TWEAK/Fn14在骨关节炎患者中的表达及其临床意义[J].川北医学院学报,2013,28(4):302-304.
[11] Park JS,Park MK,Lee SY,et al.TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis[J].Cytokine,2012,60(1):143-149.
[12] Perper SJ,Browning B,Burkly LC,et al.TWEAK is a novel arthritogenic mediator[J].J Immunol,2006,177(4):2610-2620.
[13] Kumar A,Bhatnagar S,Paul PK.TWEAK and TRAF6 regulate skeletal muscle atrophy[J].Curr Opin Clin Nutr Metab Care,2012,15(3):233-239.
[14] 陈雱,陈悦,王梓,等.肿瘤坏死因子样弱凋亡诱导因子在骨关节炎软骨细胞的表达及诱导产生MMP-9的研究意义[J].中华临床医师杂志:电子版,2012,6(10):2614-2617.
[15] 陈琼,赵明才,蒋萍,等.肿瘤坏死因子样微弱凋亡诱导因子对骨关节炎软骨细胞作用实验研究[J].检验医学与临床,2013,10(16):2065-2066.